Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA weighs benefits, risks of Novartis MS pill
FDA weighs benefits, risks of Novartis MS pill
FDA weighs benefits, risks of Novartis MS pill
Submitted by
admin
on June 8, 2010 - 6:57pm
Source:
Yahoo/AP
News Tags:
MS
FDA
multiple sclerosis
Gilenia
Headline:
FDA weighs benefits, risks of Novartis MS pill
Do Not Allow Advertisers to Use My Personal information
